PHARMACEUTICAL PREPARATION FOR THE ALLEVIATION OF ENDOMETRIOSIS

SEITZ CHRISTIAN, WASSERFALL ANNEMARIE, ZIMMERMANN HOLGER
2012
OA: closed Metadata only
⚙ AI-generated summary by qwen3.7-flash, 2026-10-05 ⓘ

This patent discloses a pharmaceutical preparation for treating endometriosis by administering 2 mg of dienogest daily in a monophasic continuous regimen for at least 169 days.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

Disclosed is the use of 17alpha-Cyanomethyl-17-beta-hydroxyestra-4,9-diene-3-one (Dienogest) for the manufacture of a pharmaceutical product for monophasic continuous administration of 2 mg Dienogest daily for at least 169 days or 25 weeks to several years to treat endometriosis.

My notes (saved in your browser only)

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

europepmc
last seen: 2026-09-02T07:05:44.937405+00:00